Sign In
Buy MKKGY
$31.01
+0.584 (+1.92%)
At Close: Jun 03, 2026
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
10:40am, Wednesday, 03'rd Jun 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
10:40am, Monday, 18'th May 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript
10:50pm, Wednesday, 13'th May 2026
Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript
Merck KGaA Q1 Earnings Call Highlights
10:08am, Wednesday, 13'th May 2026
Merck KGaA ETR: MRK reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised
Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates
08:11am, Wednesday, 13'th May 2026
Merck KGaA (MKKGY) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.59 per share a year ago.
Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
08:05am, Thursday, 30'th Apr 2026
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT0
Merck KGaA: Small Breakout In 2026, Followed By Normalization
09:48pm, Sunday, 26'th Apr 2026
Merck KGaA is rated a 'Buy' with a revised price target of €127/share, reflecting strong fundamentals and resilient business segments. I expect 2026 to be a transition year with AEPS decline due to
Short Interest in Merck KGaA (OTCMKTS:MKKGY) Grows By 20.3%
02:16am, Sunday, 19'th Apr 2026
Merck KGaA (OTCMKTS:MKKGY - Get Free Report) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 99,142 shares, an increase of 2
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Merck KGaA (MKKGY) Q4 2025 Earnings Call Transcript
05:45pm, Thursday, 05'th Mar 2026
Merck KGaA (MKKGY) Q4 2025 Earnings Call Transcript
Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript
12:16pm, Thursday, 05'th Mar 2026
Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
10:40am, Thursday, 05'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Merck KGaA (MKKGY) Lags Q4 Earnings Estimates
08:06am, Thursday, 05'th Mar 2026
Merck KGaA (MKKGY) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.54 per share a year ago.
Merck KGaA (OTCMKTS:MKKGY) Short Interest Update
02:18am, Friday, 13'th Feb 2026
Merck KGaA (OTCMKTS:MKKGY - Get Free Report) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 120,341 shares, a decline of 34.8% fro
Sanofi Names Merck KGaA's Garijo to Replace Hudson as CEO
02:08am, Thursday, 12'th Feb 2026
Garijo steps in after the drugmaker's board of directors decided not to renew Hudson's mandate.
